HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding. HPA led the round , which will help metaMe continue its preparations for Regulora’s market launch and the build out of metaMe’s commercial infrastructure.

health 91

health digital therapeutics board support 91

AsiaTechDaily

APRIL 30, 2022

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. With this investment, Biofourmis plans to scale up its virtual care offerings, according to the announcement.

digital therapeutics 52

digital therapeutics health accelerator board 52

TechCrunch

JULY 11, 2022

Arise has been able to garner support as they announced an oversubscribed seed funding round of $4 million led by BBG Ventures (investments in Alula and Reside Health) and Greycroft (investments in Bumble and Boulder Care), with participation from Iyah Romm, Cityblock co-founder and Sonder Health chairperson Sylvia Romm.

health 98

health startup data collection support 98

TechCrunch

JULY 8, 2022

According to the company, the investment is coming in the form of all equity — though they declined to share at what valuation. Movn has been able to convince investors as they have secured $20 million in a Series A funding round led by Wellington Access Ventures and Seae Ventures, with participation from Philips Ventures.

health 92

health startup enablement ventures 92

TechCrunch

MAY 12, 2023

is discussed,” said Amy Kruse, chief investment officer, Satori Neuro. Like several investors we surveyed, Kruse doesn’t solely invest in psychedelics, but they are very much on her radar. “Decriminalization is not the same as legalization at the Federal level. Will they take the lead?” Sa’ad Shah, managing partner, Noetic.

startup 99

startup digital therapeutics health development 99

TechCrunch

JULY 28, 2021

MedRhythms secured $25 million in Series B funding to advance its digital therapy platform aimed at measuring and improving someone’s ability to walk after they have experienced a neurologic injury or disease. A year ago, MedRhythms’ digital therapeutic product received Breakthrough Device designation from the U.S.

digital therapeutics 99

digital therapeutics hospitality health investment 99

TechCrunch

MARCH 14, 2022

startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K. based VC firm Optum Ventures, as it gears up to hop over the pond.

health 86

health support digital therapeutics disruption 86

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

digital therapeutics 40

digital therapeutics hospitality angel capital economic development 40

TechCrunch

FEBRUARY 6, 2023

He has also put some money where his mouth is — investing in Swedish telehealth platform, Kry , for example. Ek has long expressed a personal interest in tackling a “screwed up” healthcare system, as he put it to the Financial Times almost a decade ago.

health 85

health peer-to-peer digital therapeutics mix-use 85